Chronic wounds result from the body's inability to heal, causing pain, pathogen entry, limited treatment options, and societal burden. Diabetic foot ulcers are particularly challenging, often leading to severe complications like leg amputation. A clinical study tested AMNIODERM+®, a new device with a lyophilized human amniotic membrane (HAM), on chronic diabetic foot ulcers. Participants had diabetic neuropathic or neuroischemic leg wounds (2-16 cm2) unhealed by 20% after six weeks of standard care. This study showed significant wound healing improvements with AMNIODERM+®. The median wound size reduction after 12 weeks was 95.5%, far exceeding the null hypothesis of 20% change. Additionally, 65% of patients achieved complete ulceration healing, surpassing the 50% efficacy requirement. The median time to full closure was 11.4 weeks, with the proportion of completely healed patients rising progressively, reaching 55% by week 11. These findings, from the clinical trial "Freeze-dried amniotic membrane in the treatment of nonhealing wounds", suggest AMNIODERM+® as a promising future treatment for chronic diabetic foot ulcers. The published results were obtained as part of a clinical trial entitled "Freeze-dried amniotic membrane in the treatment of nonhealing wounds: a single-arm, retrospectively-perspective clinical trial", EUDAMED Nr. CIV-SK-22-10-041146.

BioHealing s r o Dr Slabihoudka 6232 11 708 00 Ostrava Czech Republic

Laboratory of Animal Immunology and Biotechnology Department of Animal Morphology Physiology and Genetics Faculty of AgriSciences Mendel University in Brno Zemedelska 1 613 00 Brno Czech Republic

National Institute of Endocrinology and Diabetology Kollárová 282 3 034 91 Ľubochňa Slovakia

Zobrazit více v PubMed

Baena-Díez J.M., Peñafiel J., Subirana I., Ramos R., Elosua R., Marín-Ibañez A., Grau M. Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis. Diabetes Care. 2016;39:1987–1995. doi: 10.2337/dc16-0614. PubMed DOI

World Health Organization . Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organization; Geneva, Switzerland: 2009. [(accessed on 29 August 2022)]. Available online: https://books.google.cz/books?hl=cs&lr=&id=Ycbr2e2WPdcC&oi=fnd&pg=PR5&ots=ahG2VyYdas&sig=1h6IOwVB9ZsV67QfEWDiL_Q3Ffs&redir_esc=y#v=onepage&q&f=false.

Grennan D. Diabetic Foot Ulcers. JAMA. 2019;321:114. doi: 10.1001/jama.2018.18323. PubMed DOI

Cho N.H., Shaw J.E., Karuranga S., Huang Y., da Rocha Fernandes J.D., Ohlrogge A.W., Malanda B.I.D.F. IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018;138:271–281. doi: 10.1016/j.diabres.2018.02.023. PubMed DOI

Moulik P.K., Mtonga R., Gill G.V. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26:491–494. doi: 10.2337/diacare.26.2.491. PubMed DOI

Lipsky B.A., Berendt A.R., Cornia P.B., Pile J.C., Peters E.J., Armstrong D.G., Deery H.G., Embil J.M., Joseph W.S., Karchmer A.W. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis. 2012;54:e132–e173. doi: 10.1093/cid/cis346. PubMed DOI

Everett E., Mathioudakis N. Update on management of diabetic foot ulcers. Ann. N. Y. Acad. Sci. 2018;1411:153–165. doi: 10.1111/nyas.13569. PubMed DOI PMC

Mulder G., Tenenhaus M., D’Souza G.F. Reduction of Diabetic Foot Ulcer Healing Times through Use of Advanced Treatment Modalities. Int. J. Low. Extrem. Wounds. 2014;13:335–346. doi: 10.1177/1534734614557925. PubMed DOI

Schmiedova I., Ozanova Z., Stastna E., Kiselakova L., Lipovy B., Forostyak S. Case Report: Freeze-Dried Human Amniotic Membrane Allograft for the Treatment of Chronic Wounds: Results of a Multicentre Observational Study. Front. Bioeng. Biotechnol. 2021;9:649446. doi: 10.3389/fbioe.2021.649446. PubMed DOI PMC

Burgess J.L., Wyant W.A., Abdo Abujamra B., Kirsner R.S., Jozic I. Diabetic Wound-Healing Science. Medicina. 2021;57:1072. doi: 10.3390/medicina57101072. PubMed DOI PMC

O’Toole E.A. Extracellular matrix and keratinocyte migration. Clin. Exp. Dermatol. 2001;26:525–530. doi: 10.1046/j.1365-2230.2001.00891.x. PubMed DOI

Michopoulou A., Rousselle P. How do epidermal matrix metalloproteinases support re-epithelialization during skin healing? Eur. J. Dermatol. 2015;25:33–42. doi: 10.1684/ejd.2015.2553. PubMed DOI

Solarte D.V.A., Güiza-Argüello V.R., Arango-Rodríguez M.L., Sossa C.L., Becerra-Bayona S.M. Decellularized Tissues for Wound Healing: Towards Closing the Gap Between Scaffold Design and Effective Extracellular Matrix Remodeling. Front. Bioeng. Biotechnol. 2022;10:821852. doi: 10.3389/fbioe.2022.821852. PubMed DOI PMC

Eming S.A., Koch M., Krieger A., Brachvogel B., Kreft S., Bruckner-Tuderman L., Fox J.W. Differential Proteomic Analysis Distinguishes Tissue Repair Biomarker Signatures in Wound Exudates Obtained from Normal Healing and Chronic Wounds. J. Proteome Res. 2010;9:4758–4766. doi: 10.1021/pr100456d. PubMed DOI

Goldin A. Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury. Circulation. 2006;114:597–605. doi: 10.1161/CIRCULATIONAHA.106.621854. PubMed DOI

Leaper D.J., Schultz G., Carville K., Fletcher J., Swanson T., Drake R. Extending the TIME concept: What have we learned in the past 10 years?(*) Int. Wound J. 2012;9((Suppl. S2)):1–19. doi: 10.1111/j.1742-481X.2012.01097.x. PubMed DOI PMC

Mohammed Y.A., Farouk H.K., Gbreel M.I., Ali A.M., Salah A.A., Nourelden A.Z., Gawad M.M.A.E. Human amniotic membrane products for patients with diabetic foot ulcers. Do they help? A systematic review and meta-analysis. J. Foot Ankle Res. 2022;15:71. doi: 10.1186/s13047-022-00575-y. PubMed DOI PMC

DiDomenico L.A., Orgill D.P., Galiano R.D., Serena T.E., Carter M.J., Kaufman J.P., Young N.J., Zelen C.M. Aseptically Processed Placental Membrane Improves Healing of Diabetic Foot Ulcerations: Prospective, Randomized Clinical Trial. Plast. Reconstr. Surg. Glob. Open. 2016;4:e1095. doi: 10.1097/GOX.0000000000001095. PubMed DOI PMC

Chen B., Jones R.R., Mi S., Foster J., Alcock S.G., Hamley I.W., Connon C.J. The mechanical properties of amniotic membrane influence its effect as a biomaterial for ocular surface repair. Soft Matter. 2012;8:8379. doi: 10.1039/c2sm26175h. DOI

Buerzle W., Mazza E. On the deformation behavior of human amnion. J. Biomech. 2013;46:1777–1783. doi: 10.1016/j.jbiomech.2013.05.018. PubMed DOI

Grémare A., Jean-Gilles S., Musqui P., Magnan L., Torres Y., Fenelon M., Brun S., Fricain J.C., L’heureux N. Cartography of the mechanical properties of the human amniotic membrane. J. Mech. Behav. Biomed. Mater. 2019;99:18–26. doi: 10.1016/j.jmbbm.2019.07.007. PubMed DOI

Ilic D., Vicovac L., Nikolic M., Lazic Ilic E. Human amniotic membrane grafts in therapy of chronic non-healing wounds. Br. Med. Bull. 2016;117:59–67. doi: 10.1093/bmb/ldv053. PubMed DOI

Enoch S., Leaper D.J. Basic science of wound healing. Surgery. 2008;26:31–37. doi: 10.1016/j.mpsur.2007.11.005. DOI

Frykberg R.G., Banks J. Challenges in the Treatment of Chronic Wounds. Adv. Wound Care. 2015;4:560–582. doi: 10.1089/wound.2015.0635. PubMed DOI PMC

Castellanos G., Bernabé-García Á., Moraleda J.M., Nicolás F.J. Amniotic membrane application for the healing of chronic wounds and ulcers. Placenta. 2017;59:146–153. doi: 10.1016/j.placenta.2017.04.005. PubMed DOI